Why physicians join our immunology community
Sermo’s allergy & immunology physician network provides practicing immunologists with a secure, peer-driven platform to discuss the latest in autoimmune disorders, biologic therapies, primary immunodeficiencies, and allergic disease. Whether you’re a researcher, a clinician managing complex allergy cases, or focused on translational medicine, Sermo connects you to peers facing similar challenges—from navigating payer restrictions for biologics to managing complex immune-mediated conditions.
Earn money sharing your immunology expertise
Learn why surveys are worth it for immunologists and tackle topics such as:
- Surveys on biologic switching patterns and biosimilar adoption
- Opinion polls on managing rare primary immunodeficiencies
- Research studies around patient quality of life in chronic autoimmune conditions

Discover immunology drug insights
Get practical, peer-reviewed information on immunomodulators and biologics:
- Detailed safety profiles of immunology drugs
- Comparative efficacy assessments
- Real-world tolerability experiences
- FDA approval timelines and practical use cases

Explore immunology articles and case studies
Discover strategies and real-world advice based on insights from physicians on Sermo.
- Discussing long-term management of PIDD with patients
- Showing empathy when diagnosing chronic autoimmune disorders
- Barriers to access for high-cost infusion therapies
- Emerging treatments in allergy and desensitization

Hear from fellow physician peers
Sermo has really allowed me to stay up to date with some of the most recent guidelines regarding a whole variety of different pathologies that I deal with as both a pediatric pulmonologist and pediatrician.
It has enlightened me about my practice decisions, and supported me to get quick reliable help in solving mystery cases.
I value the diversity of opinions on population and public health issues from a local practice perspective.
Frequently asked questions
Sermo’s immunology community regularly shares updates and discussions around FDA/EMA approvals, trial outcomes, and post-marketing experiences with newly released biologics and small molecule therapies.
Yes. Our drug ratings feature allows immunologists to review and compare medications across efficacy, safety, tolerability, and accessibility—based on real-world experiences from practicing physicians.
Absolutely. Sermo members frequently share information and personal experiences related to clinical trial eligibility for autoimmune and allergic conditions, patient recruitment challenges, and trial design.
Yes. Whether you work in private practice, academic medicine, or research institutions, Sermo provides a space to share your expertise and learn from others managing both clinical and translational challenges.
You’ll find case studies ranging from undiagnosed primary immunodeficiencies to complex management of systemic allergic reactions and autoimmune flares.
Yes. Many discussions in the immunology network focus on prior authorizations, insurance coverage for biologics, and how cost pressures impact clinical decision-making.
Sermo enables real-time collaboration with peers around the world. Post a case anonymously and receive input within hours—helping you make confident decisions when clarity matters most.
Sermo is designed to complement—not replace—professional societies and formal networks. It gives physicians a place for real-time peer discussion, specialty-specific insights, and opportunities to contribute to paid research, all within a physician-only community that fits easily into day-to-day practice.
If you’d like to see how Sermo compares with other physician networks such as Doximity, you can explore the differences here.
Start your immunology journey on Sermo
Become part of a dynamic immunology physician network of over 10,000 members dedicated to improving patient outcomes and advancing immune health through peer collaboration and expert insights.


